Adam P. Wax

Co-founder and President, Lumedica

Adam P. Wax, Ph.D., is co-founder and president of Lumedica; a Professor of Biomedical Engineering at Duke University, a faculty network member of the Duke Institute for Brain Sciences; and a member of the Duke Cancer Institute. His research interests include optical spectroscopy for early cancer detection, novel microscopy, and interferometry techniques. Dr. Wax is a Fellow with the American Institute for Medical and Biological Engineering, the International Society for Optics and Photonics, and the Optical Society of America.

He holds 5 patents, and his technology innovations led to his founding of Oncoscope, Inc. where serves as Chairman. Dr. Wax received a B.S. in electrical engineering from Rensselaer Polytechnic Institute, a B.S. in physics from SUNY Albany, an MA and a Ph.D. in physics from Duke University, and completed his postdoctoral training at MIT.

(Image credit: Optimec)
FIGURE 1. Optimec is830 software for visualizing contact lenses with OCT.
Detectors & Imaging

New targets for OCT in inspection and metrology

Feb. 10, 2023
Optical coherence tomography (OCT) is moving beyond the biomedical realm and offers advantages on the production line.
(Adapted from H. C. Hendargo et al., with permission from The Optical Society [OSA] [2])
This depth-resolved image of retinal vasculature, actually a composite of multiple, sequentially acquired FD-DOCT A-scans, is the product of a technique developed to overcome motion artifacts. Superficial vessels appear in red, while the deepest vessels are blue.
Detectors & Imaging

Optical Coherence Tomography: Advances in functional OCT

Jan. 24, 2017
A range of extensions enable optical coherence tomography (OCT) to achieve functional imaging, providing useful information about tissue dynamics and expanding OCT's clinical ...